Christopher Dinsmore, Ph.D., has been appointed vice president of Medicinal and Computational Chemistry at FORMA Therapeutics. Dr. Dinsmore joins the company after 19 years with Merck & Co., where he helped build the Merck Research Lab in Boston.   Dr. Dinsmore most recently served as executive director of Discovery Chemistry at Merck, where he led the discovery and advancement of seven compounds in clinical development, as well as several additional preclinical candidates. He has held vario...